Paths to Health Equity
December 4, 2017 10:00 AM- 11:00 AM ET
Presented by George Rust, MD, MPH, FAAFP, FACPM
Professor of Behavioral Sciences & Social Medicine
Director, FSU-COM Center for Medicine & Public Health
Health Disparities are a pervasive and persistent cause of preventable suffering and death, as well as excess costs. For example, we could save a baby’s life almost every day in Florida if we could eliminate the black-white infant mortality gap (348 excess infant deaths per year). This session will explore multifactorial root causes of health disparities in Florida and the U.S., ranging from social “determinants” and structural inequalities to health behaviors, as well as healthcare access and quality.
Childhood Obesity - The Causes and What We Can Do to Fight It
November 14, 2017 10:00 AM- 11:00 AM ET
Presented by Michelle Cardel PhD, RD
Assistant Professor, University of Florida
From 2011 to 2014, the prevalence of obesity among children and adolescents in the United States was 17.0 percent with non-Hispanic blacks and Hispanics having an even greater prevalence of obesity than others. Obesity is associated with a myriad of physical, social, and emotional health issues including elevated blood pressure, discrimination, and depression. In addition to poor health outcomes, obesity also contributes to widespread medical care costs upwards of $147 billion a year. Since obesity is a multifactorial disease, it is not easily attributed to one aspect of a person’s life. Previous research have indicated that genetics, environment, and behavior all play a role in the development of obesity. In this presentation, I will discuss various social determinants of health. Additionally, I will examine the current evidence for childhood obesity prevention and treatment options, as well as health policy strategies that may influence obesity-related outcomes.
The New (Old) Public Health: How Neuroscience is Changing Child and Maternal Health
February 14, 2017, 10am-11am, ET
Presented by Jeffrey P. Brosco, MD, PhD
Professor of Clinical Pediatrics, University of Miami
Largely for historical reasons, the United States health care system focuses on providing technically sophisticated medical care at the bedside and in doctor’s offices. While this approach has led to remarkable advances in clinical care, emerging research in neuroscience, epidemiology, and political science reveals that improvements in population health require new organizational approaches that challenge decades-old practice.
Is Trust-Commitment the Same as Trust-Adherence? Extending Relationship Marketing Theory into Public Health
March 14, 2017, 10am-11am, ET
Presented by John F. Riggs, DBA
Professor of Practice in Marketing, Executive Director Centurion Sales Program, Stetson University
Non-adherence to treatment regimens, preventative health initiatives, and health education programs is an ever present and multifaceted issue, the prominence of which is suggested to escalate as the population ages. The costs associated with non-adherent behaviors are far-reaching, including lost time, negative financial effects, wasted resources, and bad health outcomes. This presentation explores the determinant factors related to non-adherence behaviors through the lens of empirically tested business models. In a business context, when both commitment and trust, not just one or the other, are present, they produce outcomes that promote efficiency, productivity, and effectiveness (Morgan & Hunt 1994). Practically applied, high measures of commitment and trust produce collaborative behaviors that result in positive outcomes. Finally, we will discuss to what degree the presence of trust may impact the level of adherence.
Florida and the Cancer Moonshot
April 11, 2017, 10am-11am, ET
Presented by Christopher R. Cogle, MD
Professor of Medicine; Pierre Chagnon Professor; Scholar in Clinical Research, Leukemia & Lymphoma Society; Chairperson, Florida Cancer Control and Research Advisory Council
Each year in Florida over 100,000 people are newly diagnosed with cancer and 1.3 million Floridians are living with cancer or a cancer history. Cancer is now the leading cause of death in Florida. The advent of DNA sequencing has revealed cancer as a multi-genetic disease with subclonal architecture and multiple abilities to evade the immune system. This new and specific understanding of cancer has illuminated several promising strategies for cancer prevention and treatment. But this new comprehension of cancer and the complexity of data will require a transformation from single laboratory science to an orchestrated approach involving multiple laboratories, research centers and industry partners. Floridian examples of this transformational Cancer Moonshot work will be presented and discussed.